Long-term persistence with secukinumab in patients with moderate-to-severe psoriasis
Secukinumab demonstrated persistence in more than 70% of patients with moderate to severe psoriasis after the first year of treatment.
Authors
- Rebeca Alcalá
- Joaquín Borrás‐Blasco (ORCID: https://orcid.org/0000-0003-0248-4208)
- Alejandro Valcuende‐Rosique (ORCID: https://orcid.org/0000-0002-8455-9877)
- Silvia Cornejo
- Aldo Bono
Institutions
- Hospital de La Ribera (ES)
- Hospital de Sagunto (ES)
Publication Details
- Journal
- Farmacia Hospitalaria
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1016/j.farma.2024.10.017
- Citations
- 11
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 2.65